DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
RACLOPRIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RACLOPRIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
430K3SOZ7G
Molecule Type:
Small molecule
Molecular Formula:
C15H20Cl2N2O3
Molecular Weight:
347.24
AlogP:
2.92
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GS-441524
1
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
GS-441524
×
Maximum Phase:
1
First Approval:
None
UNII:
1BQK176DT6
Molecule Type:
Small molecule
Molecular Formula:
C12H13N5O4
Molecular Weight:
291.27
AlogP:
-1.86
PSA:
149.92
HBD:
4.0
HBA:
#RotB:
2.0
Source:
OPROZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Multiple Myeloma; Neoplasms; Waldenstrom Macroglobulinemia
26S proteosome inhibitor
OPROZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
MZ37792Y8J
Molecule Type:
Small molecule
Molecular Formula:
C25H32N4O7S
Molecular Weight:
532.62
AlogP:
0.41
PSA:
148.25
HBD:
3.0
HBA:
#RotB:
14.0
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INULINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INULINE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C32H46N2O8
Molecular Weight:
586.73
AlogP:
1.72
PSA:
132.94
HBD:
3.0
HBA:
#RotB:
8.0
Source:
GSK2816126
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Histone-lysine N-methyltransferase EZH2 inhibitor
GSK2816126
×
Maximum Phase:
1
First Approval:
None
UNII:
W4OGW9QZ97
Molecule Type:
Small molecule
Molecular Formula:
C31H38N6O2
Molecular Weight:
526.69
AlogP:
4.63
PSA:
95.05
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PALOMID-529
1
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration
Serine/threonine-protein kinase mTOR inhibitor
PALOMID-529
×
Maximum Phase:
1
First Approval:
None
UNII:
XV9409EWG4
Molecule Type:
Small molecule
Molecular Formula:
C24H22O6
Molecular Weight:
406.43
AlogP:
4.6
PSA:
78.13
HBD:
1.0
HBA:
#RotB:
6.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RP-6530
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Lymphoma, T-Cell, Cutaneous
PI3-kinase p110-delta subunit inhibitor
RP-6530
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
16.ALPHA.-BROMOEPIANDROSTERONE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
16.ALPHA.-BROMOEPIANDROSTERONE
×
Maximum Phase:
1
First Approval:
None
UNII:
9735KA370S
Molecule Type:
Small molecule
Molecular Formula:
C19H29BrO2
Molecular Weight:
369.34
AlogP:
4.33
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
FXR-450
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FXR-450
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAPOTOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
TAPOTOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
97W7N9T08G
Molecule Type:
Small molecule
Molecular Formula:
C33H41ClN2O5S
Molecular Weight:
613.22
AlogP:
5.9
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-9977
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Kidney Diseases
Mineralocorticoid receptor modulator
AZD-9977
×
Maximum Phase:
1
First Approval:
None
UNII:
6C9UKZ0CYE
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN3O5
Molecular Weight:
399.38
AlogP:
1.7
PSA:
96.97
HBD:
2.0
HBA:
#RotB:
3.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
LGX-806
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase B-raf inhibitor
LGX-806
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRODUSQUEMINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TRODUSQUEMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
KKC12PIF16
Molecule Type:
Small molecule
Molecular Formula:
C37H72N4O5S
Molecular Weight:
685.07
AlogP:
5.53
PSA:
145.94
HBD:
6.0
HBA:
#RotB:
20.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK2981278
1
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
GSK2981278
×
Maximum Phase:
1
First Approval:
None
UNII:
L49V5G013I
Molecule Type:
Small molecule
Molecular Formula:
C25H35NO5S
Molecular Weight:
461.62
AlogP:
4.4
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
10.0
Source:
SPR994
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SPR994
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAFINGOL
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SAFINGOL
×
Maximum Phase:
1
First Approval:
None
UNII:
OWA98U788S
Molecule Type:
Small molecule
Molecular Formula:
C18H39NO2
Molecular Weight:
301.52
AlogP:
4.15
PSA:
66.48
HBD:
3.0
HBA:
#RotB:
16.0
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DAROVASERTIB
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DAROVASERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
E0YF0M8O09
Molecule Type:
Small molecule
Molecular Formula:
C22H23F3N8O
Molecular Weight:
472.48
AlogP:
3.1
PSA:
135.94
HBD:
3.0
HBA:
#RotB:
4.0
Source:
GSK-376501
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-376501
×
Maximum Phase:
1
First Approval:
None
UNII:
7511RY999U
Molecule Type:
Small molecule
Molecular Formula:
C32H37NO6
Molecular Weight:
531.65
AlogP:
6.4
PSA:
79.15
HBD:
1.0
HBA:
#RotB:
12.0
Source:
TAS-119
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
TAS-119
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTX-660
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma
Unknown
ASTX-660
×
Maximum Phase:
1
First Approval:
None
UNII:
2LHZ9ZC3YO
Molecule Type:
Small molecule
Molecular Formula:
C30H42FN5O3
Molecular Weight:
539.7
AlogP:
2.31
PSA:
81.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AZD-8165
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-8165
×
Maximum Phase:
1
First Approval:
None
UNII:
7WO8I5IY24
Molecule Type:
Small molecule
Molecular Formula:
C23H21ClFN7O4
Molecular Weight:
513.92
AlogP:
2.35
PSA:
131.67
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PELCITOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
PELCITOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C57H66ClF4N6O11PS4
Molecular Weight:
1281.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
UC-781
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UC-781
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-830216
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
BMS-830216
×
Maximum Phase:
1
First Approval:
None
UNII:
ISL723GVQ8
Molecule Type:
Small molecule
Molecular Formula:
C24H22ClN2O7PS
Molecular Weight:
548.94
AlogP:
5.04
PSA:
120.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
AZD-5438
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase inhibitor
AZD-5438
×
Maximum Phase:
1
First Approval:
None
UNII:
276Z913G29
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5O2S
Molecular Weight:
371.47
AlogP:
3.38
PSA:
89.77
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
65
66
67
68
69
70
71
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA